Merz Aesthetics

FDA approves XEOMINR

Friday, July 22, 2011

Merz Aesthetics said the FDA has approved XEOMINR (incobotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe glabellar lines, or frown lines between the eyebrows, in adult patients.

[Read More]